These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23247075)

  • 1. A hypothesized mechanism for the cardiovascular risk associated with antipsychotic drug exposure and a potential preventive treatment.
    Foley DL
    Mol Psychiatry; 2014 Jan; 19(1):12-3. PubMed ID: 23247075
    [No Abstract]   [Full Text] [Related]  

  • 2. SREBP activation by antipsychotic- and antidepressant-drugs in cultured human liver cells: relevance for metabolic side-effects?
    Raeder MB; Fernø J; Vik-Mo AO; Steen VM
    Mol Cell Biochem; 2006 Sep; 289(1-2):167-73. PubMed ID: 16718372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attention to medical conditions during mental health clinic visits.
    Miller MJ
    Clin Schizophr Relat Psychoses; 2013 Oct; 7(3):149-56. PubMed ID: 23367501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of sterol regulatory element-binding protein (SREBP) in chickens.
    Khesht FA; Hassanabadi A
    Lipids Health Dis; 2012 Feb; 11():20. PubMed ID: 22309629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosphingolipid deficiency increases the sterol regulatory element-mediated gene transcription.
    Ishitsuka R; Hirabayashi Y; Kobayashi T
    Biochem Biophys Res Commun; 2009 Jan; 378(2):240-3. PubMed ID: 19017528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mental disorders and heart disease].
    Aini-yet B
    Tidsskr Nor Laegeforen; 2007 Aug; 127(16):2126-7. PubMed ID: 17717587
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of dietary protein on lipotoxicity.
    Torres N; Tovar AR
    Nutr Rev; 2007 Jun; 65(6 Pt 2):S64-8. PubMed ID: 17605316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic drug action on SREBPs-related lipogenesis and cholesterogenesis in primary rat hepatocytes.
    Lauressergues E; Staels B; Valeille K; Majd Z; Hum DW; Duriez P; Cussac D
    Naunyn Schmiedebergs Arch Pharmacol; 2010 May; 381(5):427-39. PubMed ID: 20333360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?
    Le Hellard S; Theisen FM; Haberhausen M; Raeder MB; Fernø J; Gebhardt S; Hinney A; Remschmidt H; Krieg JC; Mehler-Wex C; Nöthen MM; Hebebrand J; Steen VM
    Mol Psychiatry; 2009 Mar; 14(3):308-17. PubMed ID: 18195716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metabolic and cardiovascular health in mental disorders].
    Birkeland KI
    Tidsskr Nor Laegeforen; 2010 Feb; 130(3):285-6. PubMed ID: 20160775
    [No Abstract]   [Full Text] [Related]  

  • 11. Introduction: cardiovascular disease and metabolic risk factors in patients with mental illness.
    Newcomer JW
    CNS Spectr; 2008 Jun; 13(6 Suppl 10):1-14. PubMed ID: 18567978
    [No Abstract]   [Full Text] [Related]  

  • 12. Adverse reactions to chlorpromazine in psychiatric patients.
    Swett C
    Dis Nerv Syst; 1974 Nov; 35(11):509-11. PubMed ID: 17896459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between insulin resistance and C-reactive protein in a patient population treated with second generation antipsychotic medications.
    Kim SH; Reaven G; Lindley S
    Int Clin Psychopharmacol; 2011 Jan; 26(1):43-7. PubMed ID: 20861740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in SREBF1 and SREBF2, two antipsychotic-activated transcription factors controlling cellular lipogenesis, are associated with schizophrenia in German and Scandinavian samples.
    Le Hellard S; Mühleisen TW; Djurovic S; Fernø J; Ouriaghi Z; Mattheisen M; Vasilescu C; Raeder MB; Hansen T; Strohmaier J; Georgi A; Brockschmidt FF; Melle I; Nenadic I; Sauer H; Rietschel M; Nöthen MM; Werge T; Andreassen OA; Cichon S; Steen VM
    Mol Psychiatry; 2010 May; 15(5):463-72. PubMed ID: 18936756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic Syndrome and Cardiovascular Risk in People Treated with Long-Acting Injectable Antipsychotics.
    Sanchez-Martinez V; Romero-Rubio D; Abad-Perez MJ; Descalzo-Cabades MA; Alonso-Gutierrez S; Salazar-Fraile J; Montagud V; Facila L
    Endocr Metab Immune Disord Drug Targets; 2018; 18(4):379-387. PubMed ID: 29165095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addressing cardiometabolic risk during treatment with antipsychotic medications.
    Amiel JM; Mangurian CV; Ganguli R; Newcomer JW
    Curr Opin Psychiatry; 2008 Nov; 21(6):613-8. PubMed ID: 18852570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of psychopharmacological treatment with antipsychotic drugs on the vascular system.
    Kahl KG; Westhoff-Bleck M; Krüger THC
    Vascul Pharmacol; 2018 Jan; 100():20-25. PubMed ID: 28888918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dsc E3 ligase localization to the Golgi requires the ATPase Cdc48 and cofactor Ufd1 for activation of sterol regulatory element-binding protein in fission yeast.
    Burr R; Ribbens D; Raychaudhuri S; Stewart EV; Ho J; Espenshade PJ
    J Biol Chem; 2017 Sep; 292(39):16333-16350. PubMed ID: 28821619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective binding of sterol regulatory element-binding protein isoforms and co-regulatory proteins to promoters for lipid metabolic genes in liver.
    Bennett MK; Seo YK; Datta S; Shin DJ; Osborne TF
    J Biol Chem; 2008 Jun; 283(23):15628-37. PubMed ID: 18413311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Antipsychotic Use and Major Cardiovascular Events: A Retrospective Cohort Study.
    Szmulewicz AG; Angriman F; Pedroso FE; Vazquez C; Martino DJ
    J Clin Psychiatry; 2017; 78(8):e905-e912. PubMed ID: 28406267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.